Arphra/Issuer/BAX

BAX

Baxter International Inc.

HealthcareMedical - Instruments & SuppliesUSUSD

$18.78

-1.77%Live · FMPMay 29, 2026

AI Brief

Market cap

$9.7B

52w range

15.73 – 32.04

P / E

—

EPS

—

Volume

4.1M

Revenue · FY

$11.24B

+5.72% YoY

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$6.19M

8 txns

Net flow

−$6.19M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$16.89

Change

-42.83%

Period high

$31.72

Period low

$15.80

Period start

$29.552025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live · FMP

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-2.44%	-2.09%	+6.83%	-7.81%	+0.21%	-1.73%	-36.45%	-53.88%	-77.14%	-56.49%	+1280.88%

Aftermarket

Live · FMP

May 29, 11:30 PM

Last trade

$19.03

1,949 sh

Bid

$18.77

10 sh

Ask

$19.25

3 sh

Spread

$0.480

Sector & industry today

Live · FMP

Sectors

Basic Materials
+1.50%
Consumer Cyclical
+1.07%
Consumer Defensive
+0.80%
Industrials
+0.09%
Real Estate
-0.38%
Financial Services
-0.43%
Energy
-0.89%
Technology
-0.89%
Healthcare
-1.37%
Communication Services
-1.47%
Utilities
-2.07%

Top industries (issuer's industry highlighted)

Medical - Instruments & Supplies
-1.05%
Software - Infrastructure
+6.80%
Broadcasting
+4.85%
Copper
+4.82%
Silver
+4.70%
Coal
+4.65%
Other Precious Metals
+3.84%
Renewable Utilities
-2.84%
Gold
+2.80%
Software - Application
+2.71%
Travel Lodging
-2.70%
Staffing & Employment Services
+2.64%

Fair value

Football field →

Weighted blend

$26.46

+40.91% vs spot

Recommendation

Strong Buy

11 of 12 methods

Method spread

5bull6bear

±5% threshold

Analyst PT consensus: $19.75 (+5.17%)

Total assets

$20.06B

Total debt

$10B

Cash & equiv

$1.97B

Operating CF

$845M

Free cash flow

$323M

Buybacks

Analyst view

DB · price_targets + analyst_grades

Consensus target

$19.75

+5.17% upside

Low

$15.00

Median

$19.50

High

$25.00

Recent actions

0 ↑0 ↓8 hold

May 01, 2026
Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026

News

DB · news_items

Baxter International Still Has A Path To Upside
seekingalpha.com·May 07, 2026

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$2.7B	-$15M	$-0.03
Q4 Dec 2025	$2.97B	-$1.13B	$-2.16
Q3 Sep 2025	$2.84B	-$46M	$-0.09
Q2 Jun 2025	$2.81B	$91M	$0.18
Q1 Mar 2025	$2.63B	$126M	$0.25
Q4 Dec 2024	$2.75B	-$512M	$-1.00

Recent insiders

All →

Insider	Action	Shares	Value	Date
Mason Jeanne K officer: EVP, Chief HR Officer	Sell	64,488	$2.62M	Mar 01, 2024
STROUCKEN ALBERT P L director	Sell	3,930	$147.45K	Mar 20, 2023
Kunzler Jacqueline officer: SVP, Chief Quality Officer	Sell	3,813	$154.43K	Feb 21, 2023
Mason Jeanne K officer: SVP, Human Resources	Sell	59,477	$2.66M	Jan 17, 2023
STROUCKEN ALBERT P L director	Sell	2,805	$212.51K	Apr 05, 2022
STROUCKEN ALBERT P L director:	Sell	1,215	$93.11K	Apr 05, 2022

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$11.24B	-$308M	-$957M	$-1.75	-8.51%
FY 2024	$10.64B	$14M	-$649M	$-1.27	-6.10%
FY 2023	$10.36B	$707M	$2.66B	$5.23	+25.64%
FY 2022	$10.06B	-$2.85B	-$2.43B	$-4.83	-24.19%
FY 2021	$12.15B	$1.35B	$1.28B	$2.53	+10.57%